Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allergies Therapy
Scientists at School of Pharmacy, Department of Pharmacology detail research in allergies therapy
June 26th, 2007
New investigation results, "Effect of tecastemizole on pulmonary and cutaneous allergic inflammatory responses," are detailed in a study published in Clinical & Experimental Allergy. According to recent research from London, the United Kingdom, "Tecastemizole, a major metabolite of astemizole, is a potent and selective H1 receptor antagonist. Evidence suggests that this and certain other H1 receptor antagonists may possess anti-inflammatory effects that are, in some cases, independent of H1 receptor antagonism." "Objective The aim of this study was to investigate the anti-inflammatory effects of tectastemizole in models of allergic inflammation. Effects of...
Source: Drug Law Weekly (2007-06-26)
|
